| Laramide Resources Ltd (LAM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$18 |
Financial Statements to 31 December 2025
|
20 Mar 2026 8:54AM |
$0.770 |
$0.845 |
risen by
9.74%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,688 |
Update - Notification of buy-back - DNL
|
20 Mar 2026 8:52AM |
$3.070 |
$3.240 |
risen by
5.54%
|
|
| Hillgrove Resources Limited (HGO) ORDINARY FULLY PAID |
Materials |
$133 |
Notification regarding unquoted securities - HGO
|
20 Mar 2026 8:45AM |
$0.034 |
$0.039 |
risen by
14.71%
|
|
| Theta Gold Mines Limited (TGM) ORDINARY FULLY PAID |
Materials |
$231 |
Theta Gold Locks in Key Crushing & Screening Plant Contract
|
20 Mar 2026 8:45AM |
$0.208 |
$0.200 |
fallen by
3.61%
|
|
TGM - Price-sensitive ASX Announcement
Full Release
Key Points
- Theta Gold Mines secures a contract with NMS Africa for a crushing and screening plant.
- The plant will support the TGME Gold Project in South Africa.
- Contract is a critical step towards first gold production and early cashflows.
- The plant is designed to meet initial production needs and future expansion.
- Expected delivery of the plant is within 125 days.
- Project remains on track for commissioning in Q4 2026.
- First gold production is anticipated in Q1 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Symal Group Limited (SYL) ORDINARY FULLY PAID |
Industrials |
$576 |
Change of Director's Interest Notice - JB
|
20 Mar 2026 8:44AM |
$2.480 |
$2.410 |
fallen by
2.82%
|
|
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$6 |
$2.1 million equity raise
|
20 Mar 2026 8:43AM |
$0.005 |
$0.003 |
fallen by
40%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- $2.1 million equity raise through Entitlement Offer.
- Issuance of up to 521.7 million new shares at 0.4 cents each.
- Proceeds for working capital, oil evaluation, and Odin field upgrade.
- Equity raise supports ongoing 2P gas reserve exploitation.
- Engagement with interested parties for potential transactions.
- Supported by $5 million SA Government grant for drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IVE Group Limited (IGL) ORDINARY FULLY PAID |
Communication Services |
$409 |
Update - Notification of buy-back - IGL
|
20 Mar 2026 8:41AM |
$2.540 |
$2.660 |
risen by
4.72%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$93 |
Update - Notification of buy-back - ARA
|
20 Mar 2026 8:41AM |
$0.495 |
$0.480 |
fallen by
3.03%
|
|
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$63 |
Neurizon presents at HEALEY ALS Platform Trial Webinar
|
20 Mar 2026 8:40AM |
$0.084 |
$0.085 |
risen by
1.19%
|
|
| Premier Investments Limited (PMV) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,024 |
PMV 1H26 ASX results release and Investor Presentation
|
20 Mar 2026 8:40AM |
$12.520 |
$12.660 |
risen by
1.12%
|
|
PMV - Price-sensitive ASX Announcement
Full Release
Key Points
- Premier Investments Limited reported NPAT of $101.7 million for 1H26.
- Peter Alexander achieved sales of $312.3 million, up 4.9% on 1H25.
- Smiggle's sales decreased by 10.7% to $140.5 million.
- Premier Retail's EBIT was $119.3 million with a margin of 26.4%.
- The group declared an interim dividend of 45 cents per share.
- Smiggle plans to realign its brand identity towards the 6-12 age group.
- Peter Alexander's loyalty program, Peter's Dreamers, significantly contributed to sales.
- Premier Retail experienced a clean inventory position, with inventory down 1.9% from the previous year.
- Strategic reviews and leadership changes were made to focus on growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$88,531 |
Update - Notification of buy-back - MQG
|
20 Mar 2026 8:37AM |
$196.090 |
$232.280 |
risen by
18.46%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$143 |
Presentation - ASX SMIDCaps Conference
|
20 Mar 2026 8:37AM |
$0.505 |
$0.585 |
risen by
15.84%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$29,711 |
Notification of cessation of securities - BXB
|
20 Mar 2026 8:36AM |
$22.430 |
$22.020 |
fallen by
1.83%
|
|
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,410 |
Update - Notification of buy-back - VNT
|
20 Mar 2026 8:36AM |
$5.710 |
$5.370 |
fallen by
5.95%
|
|
| Premier Investments Limited (PMV) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,024 |
Dividend/Distribution - PMV
|
20 Mar 2026 8:36AM |
$12.520 |
$12.660 |
risen by
1.12%
|
|
| SPDR S&P 500 ETF Trust (SPY) |
Financials |
$389 |
Distribution Rate Announcement
|
20 Mar 2026 8:35AM |
$939.900 |
$995.750 |
risen by
5.94%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$40 |
Receipt Of Final Proceeds From Sale Of Non-Core Asset
|
20 Mar 2026 8:34AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia Resources Limited received C$1 million from the sale of Atocha Silver Project.
- The transaction ensures immediate financial certainty over potential future gains.
- Aguia emphasizes reallocating resources towards near-term production projects.
- The sale is part of a broader strategy to enhance portfolio value.
- The company operates mainly in Brazil and Colombia in phosphate and gold projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Premier Investments Limited (PMV) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,024 |
Appendix 4D 1H26 Half Yearly accounts
|
20 Mar 2026 8:34AM |
$12.520 |
$12.660 |
risen by
1.12%
|
|
PMV - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit for the period attributable to owners was $101,694,000.
- Total comprehensive income was $97,847,000.
- Foreign currency translation losses impacted other comprehensive income.
- The company reported strong operating cash flows.
- Investments in associates contributed positively to earnings.
- Cash and cash equivalents at the end of the period were $360,061,000.
- The report details both continuing and discontinued operations.
- Equity dividends and lease liabilities were significant factors in cash flows.
- The financial report adheres to AASB 134 Interim Financial Reporting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alliance Aviation Services Limited (AQZ) ORDINARY FULLY PAID |
Industrials |
$99 |
Change in substantial holding
|
20 Mar 2026 8:33AM |
$0.570 |
$0.615 |
risen by
7.89%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$922 |
Update - Notification of buy-back - IPH
|
20 Mar 2026 8:32AM |
$3.310 |
$3.560 |
risen by
7.55%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$17 |
MENA Orders Secured, Expanded & Operations Unaffected
|
20 Mar 2026 8:30AM |
$0.005 |
$0.006 |
risen by
20%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Memphasys maintains uninterrupted Middle East operations despite regional conflict.
- New commercial orders secured from the UAE and Iraq.
- Egypt reseller partnership confirmed and progressing through regulatory approval.
- Turkey advancing through regulatory approvals with initial commercial orders anticipated.
- Memphasys and ITL aligned on flexible supply chain logistics.
- Ongoing demand and order activity consistent with company expectations.
- Qatar operations fully operational with continued use of Felix™ System by Hamad Medical Corporation.
- Memphasys’ strategy focuses on direct clinic engagement and diversified customer base.
- Resilience of demand in IVF sector supports broader commercial expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$456 |
Chair Letter to Shareholders
|
20 Mar 2026 8:30AM |
$9.470 |
$9.040 |
fallen by
4.54%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- CLINUVEL Pharmaceuticals Limited experienced its strongest financial half-year in history.
- The company's cash reserves reached A$233 million as of December 31.
- CLINUVEL's Board decided to continue with Philippe Wolgen as CEO to ensure stability and leadership continuity.
- The vitiligo program is a priority, with ongoing interactions with global regulators and the planned start of the CUV107 study.
- The Nasdaq listing process for a Level II ADR is underway, reflecting growing U.S. investor interest.
- The company faces risks related to regulatory approval in vitiligo and pipeline product commercialization.
- Commercial programs in erythropoietic protoporphyria (EPP) are prioritized as they fuel the company's financial sustainability.
- The Chair highlighted the importance of breaking through perceived market growth ceilings for the company's share price.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$122,949 |
Redemption Notice and Letter to NAB Capital Notes 3 holders
|
20 Mar 2026 8:30AM |
$46.620 |
$40.080 |
fallen by
14.03%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,618 |
Net Tangible Asset Backing
|
20 Mar 2026 8:28AM |
$3.780 |
$4.130 |
risen by
9.26%
|
|
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$366 |
Update - Notification of buy-back - KGN
|
20 Mar 2026 8:28AM |
$3.640 |
$3.820 |
risen by
4.95%
|
|
Call 1300 880 160
Start a chat
Schedule a call
